OL
JAZZ icon

Optas LLC’s Jazz Pharmaceuticals JAZZ Stock Holding History

Optas LLC’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$343K Buy
1,422
+28
+2% +$6.13K 0.05% 281
2026
Q1 		$264K Sell
1,394
-153
-10% -$26.7K 0.04% 351
2025
Q4 		$263K Buy
+1,547
New +$237K 0.04% 343

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Optas LLC's JAZZ Position: Q2 2026 in Review

Optas LLC increased its Jazz Pharmaceuticals (JAZZ) stake by 2% in Q2 2026, buying an estimated $6.13K and bringing the position to 1,422 shares worth $343K. The position accounts for 0.05% of the portfolio, ranked #281.

Optas LLC first reported a position in JAZZ in Q4 2025 and has held it in 3 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Optas LLC held 1,422 shares of Jazz Pharmaceuticals worth $343K as of Q2 2026.
  • Optas LLC bought 28 Jazz Pharmaceuticals shares in Q2 2026, an estimated $6.13K.
  • Jazz Pharmaceuticals made up 0.05% of Optas LLC's portfolio in Q2 2026, its #281 holding.
  • Optas LLC first reported a position in Jazz Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Optas LLC's 13F filing for Q2 2026, filed 21 Jul 2026.